A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, ...

IGFBP2表达评估idh突变的胶质瘤患者生存 （IGFBP2 expression predicts IDH-mutant glioma patient survival） ...

A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...

Pediatric low-grade gliomas (pLGGs) are a group of tumors that affect children, teenagers, and young adults. They are the most common tumors of the brain and spinal cord in young people.

A group at Niigata University succeeded in the early diagnosis of leptomeningeal disease in H3K27M-mutant diffuse midline ...

A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University, has succeeded in the diagnosis ...

A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University succeeded in the diagnosis of ...

Every week, Harvard Medical School neuro-oncologist Annie Hsieh treats patients with gliomas—the most common type of brain cancer, including the deadliest, glioblastoma. After Hsieh's ...

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA ...

A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University succeeded in the diagnosis of ...